miR-181d-5pPCSK9

Yu Wang1,2,3, Fan Li1,2,3, Xiaoqian Gao1,2,3

  • 1Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.

PubMed
概括

微RNA-181d-5p通过向PCSK9.9有效降低低密度脂蛋白胆固醇 (LDL-C). 这一发现为治疗高胆固醇血症和降低心血管疾病风险提供了新的治疗途径.